Although anti-IL-17A monoclonal antibody does not directly target IL-17F, the expression of IL17F was also decreased in the CD161+ T-cell cluster in psoriasis lesional skin after IL-17A blockade (Figure 4B and Supplementary Table 3, p < 0.05). Here, KLRB1 is linked to psoriasis.